SE8107273L - 2-oxoazetidinderivat, sett att framstella democh anvendning derav - Google Patents

2-oxoazetidinderivat, sett att framstella democh anvendning derav

Info

Publication number
SE8107273L
SE8107273L SE8107273A SE8107273A SE8107273L SE 8107273 L SE8107273 L SE 8107273L SE 8107273 A SE8107273 A SE 8107273A SE 8107273 A SE8107273 A SE 8107273A SE 8107273 L SE8107273 L SE 8107273L
Authority
SE
Sweden
Prior art keywords
amino group
chem
acylated
derivatives
oxoazetide
Prior art date
Application number
SE8107273A
Other languages
English (en)
Swedish (sv)
Inventor
T Matsuo
H Masuya
N Noguchi
M Ochiai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1980/000296 external-priority patent/WO1982001872A1/fr
Priority claimed from PCT/JP1981/000102 external-priority patent/WO1982003858A1/fr
Priority claimed from PCT/JP1981/000192 external-priority patent/WO1983000690A1/fr
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE8107273L publication Critical patent/SE8107273L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8107273A 1980-12-05 1981-12-04 2-oxoazetidinderivat, sett att framstella democh anvendning derav SE8107273L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1980/000296 WO1982001872A1 (fr) 1980-12-05 1980-12-05 Derives azetidine et leur procede de preparation
PCT/JP1981/000102 WO1982003858A1 (fr) 1981-04-30 1981-04-30 Derives d'azetidine et procede de preparation
PCT/JP1981/000192 WO1983000690A1 (fr) 1981-08-25 1981-08-25 Derives d'azetidine et leur procede de preparation

Publications (1)

Publication Number Publication Date
SE8107273L true SE8107273L (sv) 1982-06-06

Family

ID=27303167

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107273A SE8107273L (sv) 1980-12-05 1981-12-04 2-oxoazetidinderivat, sett att framstella democh anvendning derav

Country Status (26)

Country Link
US (1) US4822790A (fr)
EP (1) EP0053815B1 (fr)
JP (1) JPS57131759A (fr)
KR (1) KR880001564B1 (fr)
AT (3) AT379800B (fr)
AU (1) AU551463B2 (fr)
CH (1) CH656122A5 (fr)
DE (2) DE3148020A1 (fr)
DK (1) DK534381A (fr)
ES (2) ES8301915A1 (fr)
FI (1) FI79528C (fr)
FR (1) FR2495612A1 (fr)
GB (1) GB2091723B (fr)
HU (1) HU189545B (fr)
IE (1) IE53451B1 (fr)
IL (1) IL64314A (fr)
IT (1) IT1146726B (fr)
LU (1) LU83820A1 (fr)
MX (1) MX7096E (fr)
NL (1) NL8105468A (fr)
NO (1) NO160297C (fr)
NZ (1) NZ199168A (fr)
PT (1) PT74087B (fr)
SE (1) SE8107273L (fr)
SU (2) SU1662348A3 (fr)
WO (1) WO1982002042A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU557649B2 (en) * 1981-03-30 1987-01-08 E.R. Squibb & Sons, Inc. 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts
US4734496A (en) * 1981-05-29 1988-03-29 E. R. Squibb & Sons, Inc. 4-amino derivatives of 2-oxo-1-azetidinesulfonic acid salts
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類
FR2509726B1 (fr) * 1981-07-16 1984-04-27 Squibb & Sons Inc
EP0076758B1 (fr) * 1981-10-05 1987-01-07 E.R. Squibb & Sons, Inc. Dérivés 4-éther d'acides 2-azétidinone-1-sulfoniques
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
JPS58210060A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd 2−オキソアゼチジン誘導体、その製造法および用途
JPS5916888A (ja) * 1982-07-20 1984-01-28 Takeda Chem Ind Ltd 1−スルホ−2−アゼチジノン誘導体およびその製造法
US4681937A (en) * 1982-09-27 1987-07-21 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters
JPS59101485A (ja) * 1982-11-29 1984-06-12 Otsuka Chem Co Ltd アセチジノン誘導体
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US4883869A (en) * 1984-12-20 1989-11-28 The Upjohn Company Novel beta-lactams containing amino acid substituents
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
KR890700586A (ko) * 1987-02-27 1989-04-25 로버어트 에이 아마테이지 피리돈 카르복실산 또는 산유도체를 함유하는 항균제 베타-락탐
CA1317298C (fr) * 1987-03-03 1993-05-04 Upjohn Company (The) .beta.-lactames antibiotiques activees par des groupes sulfonylaminocar bonyles
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
CA2266639A1 (fr) * 1996-09-23 1998-03-26 Rajeshwar Singh Derives d'azetidine-2-one disubstituee en 3,4 regulateurs de cysteine proteinase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6046955B2 (ja) * 1977-12-30 1985-10-18 武田薬品工業株式会社 抗生物質g−6302
JPS5549394A (en) * 1978-10-03 1980-04-09 Takeda Chem Ind Ltd Antibiotic substance sb-72310
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
CA1242188A (fr) * 1979-06-08 1988-09-20 Takeda Pharmaceutical Company Limited Derives de 3-methoxy-2-oxoazetidine et leur preparation
EP0021678B1 (fr) * 1979-06-08 1984-11-07 Takeda Chemical Industries, Ltd. Dérivés de 1-sulfo-2-azétidinone, leur préparation et leurs compositions pharmaceutiques
NZ205240A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Sulphonamide derivatives,being starting materials for producing beta-lactams
AU557649B2 (en) * 1981-03-30 1987-01-08 E.R. Squibb & Sons, Inc. 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類
FR2509726B1 (fr) * 1981-07-16 1984-04-27 Squibb & Sons Inc
FR2515182B1 (fr) * 1981-10-23 1986-05-09 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation

Also Published As

Publication number Publication date
SU1662348A3 (ru) 1991-07-07
EP0053815B1 (fr) 1985-05-08
KR830007549A (ko) 1983-10-21
NZ199168A (en) 1985-08-30
AT380471B (de) 1986-05-26
FR2495612A1 (fr) 1982-06-11
FI79528C (fi) 1990-01-10
ES513420A0 (es) 1983-04-01
US4822790A (en) 1989-04-18
ATE13178T1 (de) 1985-05-15
DK534381A (da) 1982-06-06
FR2495612B1 (fr) 1984-06-01
AU551463B2 (en) 1986-05-01
WO1982002042A1 (fr) 1982-06-24
IL64314A (en) 1988-06-30
AT379800B (de) 1986-02-25
IT8168585A0 (it) 1981-12-04
GB2091723A (en) 1982-08-04
ATA520781A (de) 1985-07-15
HU189545B (en) 1986-07-28
DE3170437D1 (en) 1985-06-13
LU83820A1 (fr) 1982-05-07
IL64314A0 (en) 1982-02-28
PT74087B (en) 1983-05-23
PT74087A (en) 1982-01-01
IE53451B1 (en) 1988-11-23
KR880001564B1 (ko) 1988-08-22
NO814113L (no) 1982-06-07
FI813851L (fi) 1982-06-06
CH656122A5 (de) 1986-06-13
MX7096E (es) 1987-06-19
NO160297C (no) 1989-04-05
ES8305325A1 (es) 1983-04-01
NO160297B (no) 1988-12-27
IT1146726B (it) 1986-11-19
IE812859L (en) 1982-06-05
AU7831381A (en) 1982-06-10
DE3148020A1 (de) 1982-10-21
GB2091723B (en) 1985-06-12
JPS57131759A (en) 1982-08-14
SU1531852A3 (ru) 1989-12-23
FI79528B (fi) 1989-09-29
NL8105468A (nl) 1982-07-01
ES507716A0 (es) 1982-12-16
ES8301915A1 (es) 1982-12-16
EP0053815A1 (fr) 1982-06-16
ATA170384A (de) 1985-10-15

Similar Documents

Publication Publication Date Title
SE8107273L (sv) 2-oxoazetidinderivat, sett att framstella democh anvendning derav
NO914558D0 (no) Fremstilling og anvendelse av kondenserte heterocykliske forbindelse
PT944617E (pt) Cristais de derivados de benzimidazole e sua producao
CA2054619A1 (fr) Derives d'aminocoumaranne, leur production et leur utilisation
DK0471236T3 (da) Imidazopyridinderivater og deres anvendelse
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
YU46998B (sh) Postupak za dobijanje derivata cefema i medjuproizvoda za iste
ES8706690A1 (es) Un procedimiento para la preparacion de nuevos derivados de penem.
ATE146476T1 (de) Cephalosporinverbindungen und verfahren zu ihrer herstellung
DE3569528D1 (en) Penem derivatives, methods of producing them, their use and pharmaceutical compositions
FI895139A0 (fi) Pyrrolidinderivat.
ES8303327A1 (es) Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina .
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.